-
COPD Treatment Landscape
David Orchard-Webb
January 19, 2024
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
-
Fluticasone Propionate API Price and Manufacturers in China
PharmaSources
June 04, 2021
Fluticasone propionate belongs to a class of drugs known as corticosteroids. It is used to manage asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis "e.g., itchy or runny nose, sneezing, watery eyes,"
-
Enrol call: Verona recruits 800 patients for COPD trial
pharmatimes
January 24, 2022
The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed with COPD.
-
Keep Asthma Under Control to Avoid Worse COVID Outcomes: Study
drugs
August 16, 2021
Uncontrolled asthma increases the risk of severe COVID-19, researchers warn.
-
GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
americanpharmaceuticalreview
August 10, 2021
GoodRx Inc., America’s leading resource for healthcare savings, and Boehringer Ingelheim, a privately owned, leading global biopharmaceutical company, announced a collaborative effort to increase access to patient savings programs on the GoodRx platform.
-
Iconovo has completed a directed share issue of SEK 75 million
firstwordpharma
July 02, 2021
The Board of Directors of Iconovo AB (publ) ("Iconovo" or the "Company") has, pursuant to the authorisation granted by the Annual General Meeting of the Company that was held on 19 May 2021, resolved on a directed share issue of 1,071,500 new shares.
-
On Father's Day, Give Dad Tips to Keep Healthy
drugs
June 21, 2021
Men tend to put their health care last, but Penn State Health offers some tips this Father's Day for ensuring guys stay healthy in the future.
-
Glenmark launches Tiogiva, tiotropium bromide dry powder inhaler in UK
expresspharma
June 16, 2021
Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in the UK for the treatment of chronic obstructive pulmonary disease (COPD).
-
Americans' Lung Health: The Poor Suffer Most
drugs
June 02, 2021
The health of your lungs may have a lot to do with the size of your bank account, a new, large study indicates.
-
Chiesi Group Receives European Marketing Authorization for Trimbow® Inhalation Powder
americanpharmaceuticalreview
April 22, 2021
Chiesi, an international research-focused healthcare group has announced that the European Commission has granted the marketing authorization for Trimbow® inhalation powder delivered through NEXThaler (beclometasone dipropionate, formoterol fumarate ...